Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-02-27 @ 4:06 PM
Study NCT ID:
NCT00580320
Status:
COMPLETED
Last Update Posted:
2016-08-18
First Post:
2007-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
Sponsor:
Virginia Commonwealth University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCC-03740
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None